Cite
APA Citation
Atkinson, V., Thienen, J., McArthur, G., Hospers, G., Long, G., Carnevale-Schianca, F., Tulyte, S., Stein, D., Bassel, M., Freivogel, K., Dalland, L., Lau, M., Legenne, P., & Ferrucci, P. (n.d.). 3337 Safety and effectiveness analysis of V600 BRAF-mutated metastatic melanoma (MM) patients (pts) from the dabrafenib (D) plus trametinib (T) named patient programme (NPP) - DESCRIBE II study. European journal of cancer, 51, S677–S678. http://access.bl.uk/ark:/81055/vdc_100030687863.0x00005a